SCHEMBL3670424

SCHEMBL3670424

CCCc1c(C(=O)Oc2cccc3c2C(=O)c2ccccc2C3=O)c(O)cc2c1C(=O)c1c(O)cccc1C2=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.68
SLC37A4 O43826 6/20 0.60
ELANE P08246 7/20 0.46
CTSG P08311 3/20 0.46
ITGA2 P17301 1/20 0.43
ALDH1A1 P00352 4/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPK1 P28482 3/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
USP2 O75604 2/20 0.42
CYP3A4 P08684 2/20 0.42
RECQL P46063 2/20 0.42
BRCA1 P38398 1/20 0.42
EGFR P00533 1/20 0.42
PIM1 P11309 1/20 0.42
LMNA P02545 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23724050 0.84 ALDH1A1 (0.49) JUNSLC37A4ELANECTSGITGA2
Anthraquinone SCHEMBL3670422 0.84 JUN (0.95) JUNSLC37A4ELANECTSGALDH1A1
SCHEMBL16227089 0.82 JUN (0.62) JUNSLC37A4ELANECTSGITGA2
SCHEMBL16431884 0.81 JUN (1.00) JUNSLC37A4ELANECTSGALDH1A1
SCHEMBL16226021 0.78 JUN (0.65) JUNSLC37A4ELANECTSGITGA2
SCHEMBL16227276 0.72 SLC37A4 (0.53) JUNSLC37A4ELANEITGA2ALDH1A1
SCHEMBL9538649 0.71 MEN1 (0.64) ELANECTSGALDH1A1MAPTMEN1
SCHEMBL10950009 0.70 TTR (0.49) ELANEALDH1A1MAPTMEN1KMT2A
SCHEMBL8952406 0.70 SLC37A4 (0.58) JUNSLC37A4ELANECTSGITGA2
SCHEMBL27584372 0.70 ELANE (0.57) ELANEALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795302-B2 Use of compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-09-14 US disclosed
US-20080070874-A1 using retinoid or tetracycline as bactericide, benzoyl peroxide as metalloproteinases (MMPs) and neutrophil elastase inhibitors; antiscarring agents; reduction in procollagen biosynthesis THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2008-03-20 US disclosed
US-7268148-B2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2007-09-11 US disclosed
US-7078048-B2 Method and compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2006-07-18 US disclosed
US-20060078582-A1 Use of compositions for treating rosacea THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2006-04-13 US disclosed
EP-1385496-A4 USE OF COMPOSITIONS FOR TREATING ROSACEA UNIV MICHIGAN (US) 2006-03-29 EP disclosed
US-20060009494-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes VOORHEES JOHN J 2006-01-12 US disclosed
US-20050277695-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes VOORHEES JOHN J 2005-12-15 US disclosed
US-20040235950-A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2004-11-25 US disclosed
EP-1385496-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2004-02-04 EP disclosed
EP-1284721-A2 COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2003-02-26 EP disclosed
US-20020183399-A1 Method and compositions for treating rosacea REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2002-12-05 US disclosed
WO-2002089743-A2 USE OF COMPOSITIONS FOR TREATING ROSACEA THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-11-14 WO disclosed
WO-2001089502-A2 COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2001-11-29 WO disclosed